Jagsonpal Pharmaceuticals P/B Ratio
Jagsonpal Pharmaceuticals (JAGSNPHARM) P/B ratio is 5.47 (High), book value per share ₹212.31 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore JAGSNPHARM intrinsic value to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
JAGSNPHARM P/B Ratio — Valuation Insights & Book Value Analysis
Jagsonpal Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 5.47 (High). For live price, earnings yield and the full fundamental profile, see Jagsonpal Pharmaceuticals stock price NSE.
- Stock appears overvalued with PB of 5.47, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 317.6% above historical average
- Trading at premium to sector average PB of -0.01
Jagsonpal Pharmaceuticals P/B Ratio Historical Trend
JAGSNPHARM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read Jagsonpal Pharmaceuticals dividend policy for the complete payout history and dividend yield track record.
JAGSNPHARM Historical P/B Ratio — Book Value Per Share & Year-End Price
Jagsonpal Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.08 | ₹212.31 | ₹228.42 | ₹276 | Moderate |
| 2025 | 1.04 | ₹184.62 | ₹192.61 | ₹240 | Moderate |
| 2024 | 1.7 | ₹143.85 | ₹244.35 | ₹187 | Moderate |
| 2023 | 1.27 | ₹122.31 | ₹155.55 | ₹159 | Moderate |
| 2022 | 1.46 | ₹102.31 | ₹149.10 | ₹133 | Moderate |
JAGSNPHARM vs Healthcare Peers — P/B Ratio Comparison
Jagsonpal Pharmaceuticals P/B 5.47 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |